Translating technologies into competitive, validated and manufacturable products to impact citizen‘s life & industry
The 12th annual MNBS Workshop, MNBS’18, was organized in Thessaloniki, Greece from 16 to 18 October 2018 in combination with the EPoSS - European Technology Platform on Smart Systems Integration - general assembly and annual forum. Applied MNBS is part of the strategic research agenda of EPoSS, driven by industry and innovation needs; both stakeholder groups have a number of synergies and common challenges on technology building blocks, system integration, manufacturing, innovation and market issues.
This technological integration into smart systems can provide ubiquitous, sustainable and cost-effective solutions to a wide range of user needs in applications like healthcare and wellbeing, agriculture and food, environment, safety and security. The MNBS community is multidisciplinary and covers several market sectors in different value chains and at different technology readiness levels (TRL). It is therefore expected to play a strong role in addressing the big challenges Europe is facing such as ageing, industrial competitiveness, personalised healthcare, food safety, climate change and quality of life, overall.
MNBS’18 has been building on the previous editions with attention to technologies integration and innovation, commercial landscapes and market development. Divided into four sessions over the two days: Day 1 concentrated on an overview of current MNBS projects and day 2 examined ecosystems, key MNBS innovation issues, future challenges and opportunities.
The community broadly recognised that the technologies and processes involved in the micro-nano biosystems have progressed significantly. Also, technology providers have collaborated successfully into obtaining integrated devices and systems, resulting in a diversity of solutions in the relevant sectors, mainly in health & care, food & beverage, and environment. The degree of sophistication of the developed technologies is very high, with the corresponding high number of scientific publications and intellectual property protection, which is promising for future developments and value creation. However, most projects struggled to deliver validated prototypes due to technical challenges, including integration and handling of the biological dimension. Furthermore, several projects suffered from delays that often limited end-user validation, usually left to end phases. In addition, cost, performances in the real field and industrialization have showed to be, in many cases, a significant challenge.